MoonLake Immunotherapeutics (MLTX) Notes Payables (2020 - 2022)

MoonLake Immunotherapeutics' Notes Payables history runs 3 years deep, the most recent figure standing at $150000.0 for Q1 2022.

• In Q1 2022, Notes Payables changed N/A year-over-year to $150000.0; the TTM figure through Mar 2022 stood at $150000.0 (changed N/A YoY), while the FY2021 annual figure was $15.0 million, up 25734.01% from the prior year.
• Notes Payables for Q1 2022 stood at $150000.0, down from $15.0 million in the prior quarter.
• The five-year high for Notes Payables was $15.0 million in Q4 2021, with the low at $58063.0 in Q4 2020.
• The 3-year median for Notes Payables is $150000.0 (2022), against an average of $5.1 million.
• Peak annual rise in Notes Payables reached 25734.01% in 2021, while the deepest fall reached 25734.01% in 2021.
• MoonLake Immunotherapeutics' Notes Payables stood at $58063.0 in 2020, then surged by 25734.01% to $15.0 million in 2021, then sank by 99.0% to $150000.0 in 2022.
• Business Quant data shows MLTX's Notes Payables at $150000.0 in Q1 2022, $15.0 million in Q4 2021, and $58063.0 in Q4 2020.